Neuralink, the tech startup owned by Elon Musk, has begun recruiting participants for its first clinical trial. The trial aims to evaluate the safety and functionality of the brain-computer interface (BCI) developed by Neuralink. The BCI, called PRIME, aims to provide people with paralysis the ability to control a computer using their thoughts. Participants will have a robot surgically implant the N1 Implant into a region of the brain that controls movement intention. The implant will then record and transmit brain signals wirelessly to an app that decodes movement intention. This trial marks a significant step forward in the development of Neuralink’s brain chip technology.
How to sign up for Neuralink’s first human clinical trial
Neuralink has started recruiting participants for its first clinical trial of the brain-computer interface (BCI) called PRIME. The trial aims to evaluate the safety and functionality of the BCI in people with paralysis. Participants will have a robot surgically implant the N1 Implant into a region of the brain that controls movement intention. The implant will then record and transmit brain signals wirelessly to an app that decodes movement intention. The goal is to enable participants to control a computer using their thoughts alone.
Implanting the Neuralink Chip
The Neuralink chip is inserted into the body using a surgical robot specially designed for the task. The robot has five built-in camera systems and uses optical coherence tomography for non-invasive imaging of brain tissue. It uses a thin needle to insert the ultra-thin flexible threads and electrodes of the chip precisely where they need to be.
